Wikidata

(Q63829888)

English

Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias

clinical trial

In more languages

Statements

title
A Phase I Open-Label Study to Assess the Safety, Tolerability and Preliminary Efficacy of TH-302, a Hypoxia-Activated Prodrug, in Patients With Advanced Leukemias (English)
0 references
medical condition
hypoxia
0 references
leukemia
0 references
start time
June 2010
0 references
end time
August 2013
0 references
number of participants
40
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63829888&oldid=1857433627"